Colette Shen, MD, PhD

University of North Carolina School of Medicine & Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina

Disclosures:

  • Employment: none
  • Compensation: none
  • Ownership: none
  • Leadership: none

Presentations

Sep 29

245 - Phase I Dose Escalation/Dose Expansion Trial of NBTXR3/SBRT in Combination with Nivolumab or Pembrolizumab for the Treatment of anti-PD-1 Naïve or Resistant Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Room 307/308
03:30pm - 03:40pm PT